These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 11006711

  • 21. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 22. Effects of lisinopril on congestive heart failure in normotensive patients with diastolic dysfunction but intact systolic function.
    Lang CC, McAlpine HM, Kennedy N, Rahman AR, Lipworth BJ, Struthers AD.
    Eur J Clin Pharmacol; 1995 Nov 02; 49(1-2):15-9. PubMed ID: 8751015
    [Abstract] [Full Text] [Related]

  • 23. Lisinopril and diltiazem reduce left ventricular mass without changing blood pressure in normotensive subjects with exaggerated blood pressure response to exercise.
    Polónia J, Martins L, Macedo F, Faria DB, Simões L, Brandão F, Gomes MC.
    Rev Port Cardiol; 1996 Mar 02; 15(3):185-93, 179. PubMed ID: 8634167
    [Abstract] [Full Text] [Related]

  • 24. Effect of angiotensin-converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure.
    Inoko M, Fujita M, Nakae I, Tamaki S, Watanuki M, Hashimoto T, Konishi T.
    Jpn Circ J; 2001 May 02; 65(5):395-8. PubMed ID: 11348042
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.
    Int J Cardiol; 2005 Aug 18; 103(2):182-6. PubMed ID: 16080978
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.
    De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, Francolini G, Bertocchi F, Ferrari R, Rizzon P, Pitzalis MV.
    Am Heart J; 2003 Nov 18; 146(5):E17. PubMed ID: 14597946
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO, Falase AO.
    Afr J Med Med Sci; 2000 Nov 18; 29(3-4):265-8. PubMed ID: 11714003
    [Abstract] [Full Text] [Related]

  • 34. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.
    Herrera-Arellano A, Miranda-Sánchez J, Avila-Castro P, Herrera-Alvarez S, Jiménez-Ferrer JE, Zamilpa A, Román-Ramos R, Ponce-Monter H, Tortoriello J.
    Planta Med; 2007 Jan 18; 73(1):6-12. PubMed ID: 17315307
    [Abstract] [Full Text] [Related]

  • 35. The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.
    Giles TD, Kerut EK, Roffidal LE, Jones R, Given MB, Hutchinson H, Tresznewsky O.
    Blood Press Monit; 2001 Apr 18; 6(2):81-4. PubMed ID: 11433128
    [Abstract] [Full Text] [Related]

  • 36. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study.
    Schrader H, Stovner LJ, Helde G, Sand T, Bovim G.
    BMJ; 2001 Jan 06; 322(7277):19-22. PubMed ID: 11141144
    [Abstract] [Full Text] [Related]

  • 37. Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.
    Cleland JG, Shah D, Krikler S, Dritsas A, Nihoyannopoulos P, Frost G, Oakley CM.
    Br Heart J; 1993 Jun 06; 69(6):512-5. PubMed ID: 8393685
    [Abstract] [Full Text] [Related]

  • 38. Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure.
    Eisenstein EL, Nelson CL, Simon TA, Smitten AL, Lapuerta P, Mark DB.
    Am Heart J; 2002 Jun 06; 143(6):1112-7. PubMed ID: 12075271
    [Abstract] [Full Text] [Related]

  • 39. [Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease].
    Pribylov SA.
    Kardiologiia; 2006 Jun 06; 46(9):36-40. PubMed ID: 17047621
    [Abstract] [Full Text] [Related]

  • 40. Study on propionyl-L-carnitine in chronic heart failure.
    Eur Heart J; 1999 Jan 06; 20(1):70-6. PubMed ID: 10075143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.